Recent Advances in the Understanding and Treatment of Health Anxiety

  • Peter TyrerEmail author
Anxiety Disorders (A Pelissolo, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Anxiety Disorders


Purpose of Review

To examine the diagnosis of health anxiety, its prevalence in different settings, public health significance, treatment, and outcome.

Recent Findings

Health anxiety is similar to hypochondriasis but is characterized by fear of, rather than conviction of, illness. Lifetime prevalence rates are 6% in the population and as high as 20% in hospital out-patients, leading to greater costs to health services through unnecessary medical contacts. Its prevalence may be increasing because of excessive internet browsing (cyberchondria). Drug treatment with antidepressants has some efficacy but is not well-liked, but psychological treatments, including cognitive behavior therapy, stress management, mindfulness training, and acceptance and commitment therapy, given either individually, in groups, or over the Internet, have all proved efficacious in both the short and longer term. Untreated health anxiety leads to premature mortality.


Health anxiety has become an increasing clinical and public health issue at a time when people are being formally asked to take more responsibility in monitoring their own health. More attention by health services is needed.


Illness anxiety Health anxiety Cyberchondria Psychological treatments 



Much of the research work described in this paper was funded by the National Coordinating Centre for Health Technology Assessment (NCCHTA) of the UK. Figure 1 is reproduced by permission of the Health Technology Assessment Program.

Compliance with Ethical Standards

Conflict of Interest

Peter Tyrer declares no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• American Psychiatric Association. Illness anxiety. In: Diagnostic and statistical manual of mental disorders, 5th Revision (DSM-5). Washington, DC: American Psychiatric Association; 2015. p. 315. The only formal definition of health anxiety currently available; the ICD-11 one will be published in 2018. The DSM-5 is a good definition but does not include rumination, usually considered to be an important aspect of the condition. Google Scholar
  2. 2.
    Fink P, Ørnbøl E, Toft T, Sparle KC, Frostholm L, Olesen F. A new, empirically established hypochondriasis diagnosis. Am J Psychiatry. 2004;161:1680–91.CrossRefPubMedGoogle Scholar
  3. 3.
    Tyrer P, Tyrer H. Health anxiety: detection and treatment. BJPsych Adv. 2018;24:66–72.CrossRefGoogle Scholar
  4. 4.
    Tyrer P, Eilenberg T, Fink P, Hedman E, Tyrer H. Health anxiety: the silent treatable epidemic. BMJ. 2016;353:i2250.CrossRefPubMedGoogle Scholar
  5. 5.
    Pilowsky I. Dimensions of hypochondriasis. Br J Psychiatry. 1967;113:89–93.CrossRefPubMedGoogle Scholar
  6. 6.
    Kellner R, Abbott P, Winslow WW, Pathak D. Fears, beliefs, and attitudes in DSM-III hypochondriasis. J Nerv Ment Dis. 1987;175:20–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Salkovskis PM, Rimes KA, Warwick HMC, Clark DM. The health anxiety inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002;32:843–53.CrossRefPubMedGoogle Scholar
  8. 8.
    Lucock MP, Morley S. The health anxiety questionnaire. Br J Health Psychol. 1996;1:137–50.CrossRefGoogle Scholar
  9. 9.
    Axelsson E, Andersson E, Ljótsson B, Wallhed Finn D, Hedman E. The health preoccupation diagnostic interview: inter-rater reliability of a structured interview for diagnostic assessment of DSM-5 somatic symptom disorder and illness anxiety disorder. Cogn Behav Ther. 2016;45:259–69.CrossRefPubMedGoogle Scholar
  10. 10.
    Fink P, Ewald H, Jensen J, Sørensen L, Engberg M, Holm M, et al. Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization. J Psychosom Res. 1999;46(3):261–73.CrossRefPubMedGoogle Scholar
  11. 11.
    Speckens AE, Van Hemert AM, Spinhoven P, Bolk JH. The diagnostic and prognostic significance of the whitely index, the illness attitude scales and the somatosensory amplification scale. Psychol Med. 1996;26:1085–90.CrossRefPubMedGoogle Scholar
  12. 12.
    Hedman E, Lekander M, Ljótsson B, Lindefors N, Rück C, Andersson G, et al. Optimal cut-off points on the health anxiety inventory, illness attitude scales and Whiteley index to identify severe health anxiety. PLoS One. 2015;10:e0123412.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tyrer P, Tyrer H, Morriss R, Crawford M, Cooper S, Yang M, et al. Clinical and cost-effectiveness of adapted cognitive behaviour therapy for non-cardiac chest pain: multicentre, randomised controlled trial. Open Heart. 2017;4:e000582.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Stein DJ, Kogan CS, Atmaca M, Fineberg NA, Fontenelle LE, Grant JE, et al. The classification of obsessive-compulsive and related disorders in the ICD-11. J Affect Disord. 2016;190:663–74.CrossRefPubMedGoogle Scholar
  15. 15.
    Hedman E, Ljótsson B, Axelsson E, Andersson G, Rück C, Andersson E. Health anxiety in obsessive compulsive disorder and obsessive compulsive symptoms in severe health anxiety: an investigation of symptom profiles. J Anxiety Disord. 2017;45:80–6.CrossRefPubMedGoogle Scholar
  16. 16.
    • Scarella TM, Laferton JA, Ahern DK, Fallon BA, Barsky A. The relationship of hypochondriasis to anxiety, depressive and somatoform disorders. Psychosomatics. 2016;200-7:57. A good account of the phenomenology of health anxiety and why it should be probably be regarded as an anxiety disorder. Google Scholar
  17. 17.
    • Sunderland M, Newby JM, Andrews G. Health anxiety in Australia: prevalence, comorbidity, disability and service use. Br J Psychiatry. 2013;202:56–61. The best epidemiological study of health anxiety to date. CrossRefPubMedGoogle Scholar
  18. 18.
    Bobevski I, Clarke DM, Meadows G. Health anxiety and its relationship to disability and service use: findings from a large epidemiological survey. Psychosom Med. 2016;78:13–25.CrossRefPubMedGoogle Scholar
  19. 19.
    Tyrer H, Ali L, Cooper F, Seivewright P, Bassett P, Tyrer P. The schedule for evaluating persistent symptoms (SEPS): a new method of recording medically unexplained symptoms. Int J Soc Psychiatry. 2013;59:281–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Tyrer P, Cooper S, Crawford M, Dupont S, Green J, Murphy D, et al. Prevalence of health anxiety problems in medical clinics. J Psychosom Res. 2011;71:392–4.CrossRefPubMedGoogle Scholar
  21. 21.
    Thorgaard MV. Health anxiety and illness behaviour in children of mothers with severe health anxiety. Dan Med J. 2017;64:B5365.Google Scholar
  22. 22.
    Fink P, Ømbol E, Christensen KS. The outcome of health anxiety in primary care: a two-year follow-up study on health care costs and self-rated health. PLoS One. 2010;24:e9873.CrossRefGoogle Scholar
  23. 23.
    •• Tyrer P, Salkovskis P, Tyrer H, Wang D, Crawford MJ, Dupont S, et al. Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years. Health Technol Assess. 2017;21:1–58. A monograph publication giving a comprehensive account of the management of health anxiety among medical out-patients, a place where health anxiety is very common. CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Adler G. The physician and the hypochondriacal patient. N Engl J Med. 1981;304:1394–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Greeven A, van Balkom AJLM, Visser S, Merkelbach JW, van Rood YR, van Dyck R, et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. Am J Psychiatry. 2007;164:91–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Fallon BA, Petkova E, Skritskaya N, Sanchez-Lacay A, Schneier F, Vermes D, et al. A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. J Clin Psychopharmacol. 2008;28:638–45.CrossRefPubMedGoogle Scholar
  27. 27.
    Greeven A, van Balkom AJ, van der Leeden R, Merkelbach JW, van den Heuvel OA, Spinhoven P. Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up. J Behav Ther Exp Psychiatry. 2009;40:487–96.CrossRefPubMedGoogle Scholar
  28. 28.
    • Fallon BA, Ahern DK, Pavlicova M, Slavov I, Skritskya N, Barsky AJ. A randomized controlled trial of medication and cognitive-behavioral therapy for hypochondriasis. Am J Psychiatry. 2017;174:756–64. An interesting paper that illustrates the difficulties of carrying out a trial of psychological and drug treatments. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Walker J, Vincent N, Furer P, Cox B, Kjernisted K. Treatment preference in hypochondriasis. J Behav Ther Exp Psychiatry. 1998;30:251–8.CrossRefGoogle Scholar
  30. 30.
    Olatunji BO, Kauffman BY, Meltzer S, Davis ML, Smits JA, Powers MB. Cognitive-behavioral therapy for hypochondriasis/health anxiety: a meta-analysis of treatment outcome and moderators. Behav Res Ther. 2014;58:65–74.CrossRefPubMedGoogle Scholar
  31. 31.
    Salkovskis PM, Warwick HM. Morbid preoccupations, health anxiety and reassurance: a cognitive-behavioural approach to hypochondriasis. Behav Res Ther. 1986;24:597–602.CrossRefPubMedGoogle Scholar
  32. 32.
    Tyrer P, Cooper S, Salkovskis P, Tyrer H, Crawford M, Byford S, et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. Lancet. 2014;383:219–25.CrossRefPubMedGoogle Scholar
  33. 33.
    Bourgault-Fagnou MD, Hadjistavropoulos HD. A randomized trial of two forms of cognitive behaviour therapy for an older adult population with subclinical health anxiety. Cogn Behav Ther. 2013;42:31–44.CrossRefPubMedGoogle Scholar
  34. 34.
    Tyrer H, Tyrer P, Lissemann-Stones Y, McAllister S, Cooper S, Salkovskis P, et al. Therapist differences in a randomised trial of the outcome of cognitive behaviour therapy for health anxiety in medical patients. Int J Nurs Stud. 2015;52:686–94.CrossRefPubMedGoogle Scholar
  35. 35.
    Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA. 2004;292:1464–70.CrossRefGoogle Scholar
  36. 36.
    Seivewright H, Green J, Salkovskis P, Barrett B, Nur U, Tyrer P. Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial. Br J Psychiatry. 2008;193:332–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Sørensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol Med. 2011;41:431–41.CrossRefPubMedGoogle Scholar
  38. 38.
    Weck F, Neng JM, Richtberg S, Jakob M, Stangier U. Cognitive therapy versus exposure therapy for hypochondriasis (health anxiety): a randomized controlled trial. J Consult Clin Psychol. 2015;83:665–76. (n=84)CrossRefPubMedGoogle Scholar
  39. 39.
    Clark DM, Salkovskis PM, Hackmann A, Wells A, Fennell M, Ludgate J, et al. Two psychological treatments for hypochondriasis. A randomised controlled trial. Br J Psychiatry. 1998;173:218–25.CrossRefPubMedGoogle Scholar
  40. 40.
    Hedman E, Ljótsson B, Andersson E, Rück C, Andersson G, Lindefors N. Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial. Cogn Behav Ther. 2010;39:239–50.CrossRefPubMedGoogle Scholar
  41. 41.
    McManus F, Surawy C, Muse K, Vazquez-Montes M, Williams JM. A randomized trial of mindfulness-based cognitive therapy versus unrestricted services for health anxiety (hypochondriasis). J Consult Clin Psychol. 2012;80:817–28.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Weck F, Gropalis M, Hiller W, Bleichhardt G. Effectiveness of cognitive-behavioral group therapy for patients with hypochondriasis (health anxiety). J Anxiety Disord. 2015;30:1–7.CrossRefPubMedGoogle Scholar
  43. 43.
    •• Hedman E, Andersson G, Andersson E, Ljotsson B, Ruck C, Asmundson GJ, et al. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2011;230–6:198. The best account of internet delivered cognitive behavior therapy. Google Scholar
  44. 44.
    Hedman E, Axelsson E, Görling A, Ritzman C, Ronnheden M, El Alaoui S, et al. Internet-delivered cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2014;205:307–14.CrossRefPubMedGoogle Scholar
  45. 45.
    Hedman E, Axelsson E, Andersson E, Lekander M, Ljótsson B. Exposure-based cognitive-behavioural therapy via the internet and as bibliotherapy for somatic symptom disorder and illness anxiety disorder: randomised controlled trial. Br J Psychiatry. 2016;209:407–13.CrossRefPubMedGoogle Scholar
  46. 46.
    • Weck F, Neng JM, Schwind J, Höfling V. Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial. J Anxiety Disord. 2015;34:1–7.CrossRefPubMedGoogle Scholar
  47. 47.
    • Eilenberg T, Fink P, Jensen JS, Rief W, Frostholm L. Acceptance and commitment group therapy (ACT-G) for health anxiety: a randomized controlled trial. Psychol Med. 2016;46:103–15. A useful account of the methodology of a good group intervention. CrossRefPubMedGoogle Scholar
  48. 48.
    Tyrer P, Crawford M, Sanatinia R, Tyrer H, Cooper S, Muller-Pollard C, et al. Preliminary studies of the ICD 11 classification of personality disorder in practice. Personal Ment Health. 2014;8:254–63.CrossRefPubMedGoogle Scholar
  49. 49.
    Newton-Howes G, Tyrer P, Johnson T. Personality disorder and the outcome of depression: a meta-analysis of published studies. Br J Psychiatry. 2006;188:13–20.CrossRefPubMedGoogle Scholar
  50. 50.
    Newton-Howes G, Tyrer P, Johnson T, Mulder R, Kool S, Dekker J, et al. Influence of personality on the outcome of treatment in depression: systematic review and meta-analysis. J Personal Disord. 2014;28:577–93.CrossRefGoogle Scholar
  51. 51.
    Skodol AE, Geier T, Grant BF, Hasin DS. Personality disorders and the persistence of anxiety disorders in a nationally representative sample. Depress Anxiety. 2014;31:721–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Sanatinia R, Wang D, Tyrer P, Tyrer H, Cooper S, Crawford M, et al. The impact of personality status on the cost and outcomes of cognitive behaviour therapy for health anxiety. Br J Psychiatry. 2016;209:244–50.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Tyrer P, Wang D, Tyrer H, Crawford M, Cooper S. Dimensions of dependence and their influence on the outcome of cognitive behaviour therapy for health anxiety: randomized controlled trial. Personal Ment Health. 2016;10:96–105.CrossRefPubMedGoogle Scholar
  54. 54.
    Hedman E, Andersson G, Lindefors N, Gustavsson P, Lekander M, Rück C, et al. Personality change following internet-based cognitive behavior therapy for severe health anxiety. PLoS One. 2014;9:e113871.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One. 2010;5:e13196.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Barsky AJ, Ettner SL, Horsky J, Bates DW. Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care. 2001;39:705–15.CrossRefPubMedGoogle Scholar
  57. 57.
    Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62:903–10.CrossRefPubMedGoogle Scholar
  58. 58.
    Eilenberg T, Frostholm L, Schröder A, Jensen JS, Fink P. Long-term consequences of severe health anxiety on sick leave in treated and untreated patients: analysis alongside a randomised controlled trial. J Anxiety Disord. 2015;32:95–102.CrossRefPubMedGoogle Scholar
  59. 59.
    Mykletun A, Heradstveit O, Eriksen K, Glozier N, Øverland S, Maeland JG, et al. Health anxiety and disability pension award: the HUSK study. Psychosom Med. 2009;71:353–60.CrossRefPubMedGoogle Scholar
  60. 60.
    Seivewright H, Salkovskis P, Green J, Mullan N, Behr G, Carlin E, et al. Prevalence and service implications of health anxiety in genitourinary medicine clinics. Int J STD AIDS. 2004;15:519–22.CrossRefPubMedGoogle Scholar
  61. 61.
    Hedman E, Andersson E, Lindefors N, Andersson G, Rück C, Ljótsson B. Cost-effectiveness and long-term effectiveness of internet-based cognitive behaviour therapy for severe health anxiety. Psychol Med. 2013;43:363–74.CrossRefPubMedGoogle Scholar
  62. 62.
    Kobori O, Okita M, Shiraishi T, Hasegawa T, Iyo M. Health anxiety and healthcare costs in Japanese individuals: an Internet survey. Health Psychol Behav Med. 2014;2:833–40.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Tyrer H, Tyrer P, Barrett B. Influence of dependent personality status on the outcome and health service costs of health anxiety. Int J Soc Psychiatry. 2013;59:274–80.CrossRefPubMedGoogle Scholar
  64. 64.
    Hedman E, Andersson E, Ljótsson B, Axelsson E, Lekander M. Cost effectiveness of internet-based cognitive behaviour therapy and behavioural stress management for severe health anxiety. BMJ Open. 2016;6:e009327.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Barrett B, Tyrer P, Tyrer H, Cooper S, Crawford MJ, Byford S. An examination of the factors that influence costs in medical patients with health anxiety. J Psychosom Res. 2012;73:59–62.CrossRefPubMedGoogle Scholar
  66. 66.
    •• Berge LI, Skogen JC, Sulo G, Igland J, Wilhelmsen I, Vollset SE, et al. Health anxiety and risk of ischaemic heart disease: a prospective cohort study linking the Hordaland Health Study (HUSK) with the Cardiovascular Diseases in Norway (CVDNOR) project. BMJ Open. 2016;6:e012914. An important paper showing the medical risks of untreated health anxiety.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Van Beek MH, Zuidersma M, Lappenschaar M, Pop G, Roest AM, Van Balkom AJ, et al. Prognostic association of cardiac anxiety with new cardiac events and mortality following myocardial infarction. Br J Psychiatry. 2016;209:400–6.CrossRefPubMedGoogle Scholar
  68. 68.
    Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171:453–62.CrossRefPubMedGoogle Scholar
  69. 69.
    Tolmunen T, Lehto SM, Julkunen J, Hintikka J, Kauhanen J. Trait anxiety and somatic concerns associate with increased mortality risk: a 23-year follow-up in aging men. Ann Epidemiol. 2014;24:463–8.CrossRefPubMedGoogle Scholar
  70. 70.
    Kikkenborg Berg S, Caspar Thygesen L, Hastrup Svendsen J, Vinggaard Christensen A, Zwisler AD. Anxiety predicts mortality in ICD patients: results from the cross-sectional national CopenHeartICD survey with register follow-up. Pacing Clin Electrophysiol. 2014;37:1641–50.CrossRefPubMedGoogle Scholar
  71. 71.
    Tan MP, Morgan K. Psychological interventions in cardiovascular disease: an update. Curr Opin Psychiatry. 2015;28:371–7.CrossRefPubMedGoogle Scholar
  72. 72.
    Tyrer P, Tyrer H, Cooper S, Barrett B, Kings S, Lazarevic V, et al. Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluation. BMC Psychology. 2015;3:41.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Muse K, McManus F, Leung C, Meghreblian B, Williams JM. Cyberchondriasis: fact or fiction? A preliminary examination of the relationship between health anxiety and searching for health information on the Internet. J Anxiety Disord. 2012;26:189–96.CrossRefPubMedGoogle Scholar
  74. 74.
    Chambers JB, Marks EM, Russell V, Hunter MS. A multidisciplinary, biopsychosocial treatment for non-cardiac chest pain. Int J Clin Pract. 2015;69:922–7.CrossRefPubMedGoogle Scholar
  75. 75.
    Patel S, Malins S, Guo B, James M, Kai J, Kaylor-Hughes C, et al. Protocol investigating the clinical outcomes and cost-effectiveness of cognitive-behavioural therapy delivered remotely for unscheduled care users with health anxiety: randomised controlled trial. BJPsych Open. 2016;2:81–7.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Centre for PsychiatryImperial CollegeLondonUK

Personalised recommendations